KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Exchange Rate Effect (2021 - 2025)

Ginkgo Bioworks Holdings' Exchange Rate Effect history spans 5 years, with the latest figure at -$152000.0 for Q4 2025.

  • For Q4 2025, Exchange Rate Effect fell 108.22% year-over-year to -$152000.0; the TTM value through Dec 2025 reached $201000.0, up 171.53%, while the annual FY2025 figure was $201000.0, 171.53% up from the prior year.
  • Exchange Rate Effect reached -$152000.0 in Q4 2025 per DNA's latest filing, down from $93000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $1.1 million in Q4 2022 to a low of -$469000.0 in Q2 2023.
  • Average Exchange Rate Effect over 5 years is $12277.8, with a median of -$21000.0 recorded in 2023.
  • The largest YoY upside for Exchange Rate Effect was 10090.91% in 2022 against a maximum downside of 987.5% in 2022.
  • A 5-year view of Exchange Rate Effect shows it stood at -$11000.0 in 2021, then skyrocketed by 10090.91% to $1.1 million in 2022, then tumbled by 90.72% to $102000.0 in 2023, then crashed by 171.57% to -$73000.0 in 2024, then tumbled by 108.22% to -$152000.0 in 2025.
  • Per Business Quant, the three most recent readings for DNA's Exchange Rate Effect are -$152000.0 (Q4 2025), $93000.0 (Q3 2025), and $186000.0 (Q2 2025).